Abstract
Clinical measurements quantitating glucocorticoid receptor sites in leukemic blasts may give useful prognostic information. In childhood ALL, where the most data is available, “high” receptor content in peripheral or marrow blasts correlated with likelihood of remission on therapy, longer durations of remission and better prognosis generally. In lymphomas and CLL as well, high receptor content correlated with likelihood of response to steroid therapy, though the number of studies is less. In AML the correlation with receptor site content is moot, and in other leukemias the reports are less complete.
A model system for childhood ALL is provided by CEM cells, a glucocorticoid sensitive human cell line from a patient with the disease. These cells have glucocorticoid receptors which must be filled by hormone for >24 hr for cell lysis to begin. Four types of glucocorticoid resistance have been identified thus far in clones of these cells. Their distinctive properties are described and their relevance to clinical situations briefly discussed.
Work supported in part by a grant from the National Cancer Institute (CA 32226)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
M. E. Wolfe, Structure-activity relationship in glucocorticoids. In: Glucocorticoid Hormone Action. J.D. Baxter & G.G. Rousseau (eds.), Springer-Verlag, Berlin, 1979, pp. 97–107.
F. W. Ruscetti and R. C. Gallo, Human T-lymphocyte growth factor: Regulation of growth and function of T-lymphocytes. Blood 57: 379 (1981)
S. Gillis, G. R. Crabtree, and K. A. Smith, Glucocorticoidinduced inhibition of T-cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J. Immunol. 123: 1624 (1979).
E.-L. Larsson, Cyclosporin A and dexamethasone suppress T cell response by selectively acting at distinct sites of the triggering process. J. Immunol. 124: 2828 (1980).
S. K. Arya, F. Wong-Staal and R. C. Gallo, Dexamethasone-mediated inhibition of human T-cell growth factor and gamma interferon messenger RNA. J. Immunol. 133: 273 (1984)
G. R. Adolf and P. Swetly, Glucocorticoid hormones inhibit DNA synthesis and enhance interferon production in a human lymphoid cell line. Nature 282: 736 (1979).
U. Zor, R. Ben-Sort, I. Maoz, D. Wallach and D. Gurari-Rotman, Inhibition by glucocorticosteroid hormones of interferon and prostaglandin E by poly (rI).poly (rC). J. Gen. Virol. 63: 359 (1982).
G. R. Adolf and P. Swetly, Interferon production in hematopoietic cell lines: Response to chemicals and characterization of interferons. J. Interferon Res. 2: 261 (1982).
T. Kasahara, J. J. Hooks, S. F. Dougherty and J. J. Oppenheim, Interleukin 2-mediated immune interferon (IFN-) production by human T cells and T cell subsets. J. Immunol. 130: 1784 (1983).
R. Palacios and I. Sugarawa, Hydrocortisone abrogates proliferation of T cells in autologous mixed lymphocyte reaction by rendering the interleukin 2 producer T cells unresponsive to interleukin 1 and unable to synthesize the T-cell growth factor. Scand. J. Immunol. 15: 25 (1982).
C. H. Sibley and K. R. Yamamoto, Mouse lymphoma cells: Mechanism of resistance of glucocorticoids. In: Glucocorticoid Hormone Action. J. D. Baxter and G. G. Rousseau, (eds.), Springer-Verlag, Berlin, 1979, Chapter 20, pp. 357–376.
S. Bourgeois, R. F. Newby and M. Huet, Glucocorticoid resistance in murine lymphoma and thymoma lines. Cancer Res. 38: 4279 (1978).
J. Stevens and Y. Stevens, Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma. Cancer Res. 39: 4011 (1979).
M. E. Lippman, R. H. Halterman, B. C. Leventhal, S. Perry and E. B. Thompson, Glucocorticoid-binding proteins in human acute lymphoblastic leukemic blast cells. J. Clin. Invest. 52: 1715 (1973).
J. Wolff, C. Brubaker, M. Murphy, M. Pierce, and N. Severo, Prednisone therapy of acute childhood leukemia: Prognosis and duration of response in 330 treated patients. J. Pediatr. 70: 626 (1967).
O. Pearson and L. Eltel, Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias. JAMA 144: 1349 (1950).
M. E. Lippman, G. K. Yarbro and B. G. Leventhal, Clinical implications of glucocorticoid receptors in human leukemia. Cancer Res. 38: 4251 (1978).
F. Homo, D. Duval, J. L. Harousseau, J. P. Marie and R. Zittour, Heterogeneity of the in vitro responses to glucocorticoids in acute leukemia. Cancer Res. 40: 2601 (1980).
R. Mastrangelo, R. Malandrino, R. Riccardi, P. Longo, F. O. Ranelletti and S. Iacobelli, Clinical implications of glucocorticoid receptor studies in childhood acute lymphoblastic leukemia. Blood 56: 1036 (1980).
A. D. Ho, W. Aunstein and W. Schmid, Glucocorticoid receptors and sensitivity in leukemias. Blut 42: 183 (1981).
M. E. Costlow, C. Pui and G. V. Dahl, Glucocorticoid receptors in childhood acute lymphoblastic leukemia. Cancer Res. 42: 4801 (1982).
P. Nanni, G. Nicoletti, G. Prodi, M. C. Galli, C. DeGiovanni, S. Grilli, P.-L Lollini, M. Gobbi, M. Cavo, and S. Tura, Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemia. Cancer 49: 623 (1982).
C.-H. Pui, G. V. Dahl, G. Rivera, S. B. Murphy and M. E. Costlow, The relationship of blast cells glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leuk. Res. 8: 579 (1984).
C. D. Bloomfield, B. A. Peterson, J. Zaleskas, G. Frizzera, K. A. Smith, L. Hilebrandt, K. Gajl-Peczalska and A. Munck, In-vitro glucocorticoid studies for predicting response to glucocorticoid therapy in adults with malignant lymphoma. The Lancet 1: 952 (1980).
B. Terenius, B. Simonsson and K. Nilsson, Glucocorticoid receptors in chronic lymphocytic leukaemia. In: Glucocorticoid Action and Leukemia, 7th Tenovus Workshop, P. A. Bell and N. M. Borthwick (eds). Alpha Omego Publishing, Ltd., Cardiff, 1978, pp. 155–159.
T. J. Schmidt and E. B. Thompson, Glucocorticoid receptors and glutamine synthetase in leukemic Sezary cells. Cancer Res. 39: 376 (1979).
M. E. Lippman, S. Perry and E. B. Thompson, Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia. Am. J. Med. 59: 224 (1975).
S. Iacobelli, F. Ranelletti, F. O. Longo, P. Riccardi and R. Mastrangelo, Discrepancies between in vivo and in vitro effects of glucocorticoids in myelomonocytic leukemic cells with steroid receptors. Cancer Res. 38: 4257 (1978).
G. Crabtree, K. Smith and A. Munck, Glucocorticoid receptors and sensitivity of isolated human leukemia and lymphoma cells. Cancer Res. 38: 4268 (1978).
N. J. Holbrook, C. D. Bloomfield and A. Munck, Stabilization of labile glucocorticoid-receptor complexes from acute nonlymphocytic leukemia cells by a factor from chronic lymphocytic leukemia cells. Cancer Res. 44: 407 (1984).
L. Skoog, B. Nordenskjold, A. Ost, B. Andersson, R. Hast, N. Giannoulis, S. Humla, T. Hagerstrom and P. Reizenstein, Glucocorticoid receptor concentrations and terminal transferase activity as indicators of prognosis in acute nonlymphocytic leukaemia. British Med. J. 282: 1826 (1981).
M. E. Costlow, C. Pui and G. V. Dahl, Glucocorticoid receptors in childhood acute lymphoblastic leukemia. Cancer Res. 42: 4801 (1982).
G. S. Konior, M. E. Lippman, G. E. Johnson and B. G. Leventhal, Glucocorticoid receptors in subpopulations of childhood acute lymphocytic leukemia. Cancer Res. 37: 2688 (1977).
M. E. Lippman, G. S. K. Yarbro and B. Leventhal, Glucocorticoid receptors in normal and leukaemic human leucocytes. In: Glucocorticoid Action and Leukaemia. Seventh Tenovus Workshop, P. A. Bell and N. M. Borthwick (eds.), Alpha Omega Publishing Ltd., Cardiff, 1978, pp. 175–190.
G. E. Foley, H. Lazarus, S. Farber, B. F. Uzman, B. A. Boone and R. E. McCarthy, Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18: 522 (1965).
M. R. Norman, J. M. Harmon, and E. B. Thompson, Use of a human lymphoid cell line to evaluate interactions between prednisolone and other chemotherapeutic agents. Cancer Res. 38: 4273 (1978).
J. M. Harmon, M. R. Norman, B. J. Fowlkes and E. B. Thompson, Dexamethasone induces irreversible G, arrest and death of a human lymphoid cell line. J. Cell. Physiol. 98: 267 (1979).
R. Zawydiwski, J. M. Harmon and E. B. Thompson, Glucocorticoidresistant human acute lymphoblastic leukemia cell line with functional receptor. Cancer Res. 43: 3865 (1983).
J. M. Harmon and E. B. Thompson, Glutamine synthetase induction by glucocorticoids in the glucocorticoid-sensitive human leukemic cell line CEM-C7. J. Cell. Physiol. 110: 155 (1982).
E. B. Thompson, J. R. Smith, S. Bourgeois and J. M. Harmon, Glucocorticoid receptors and human leucopathic diseases. In: Proceedings of the 1983 Schering Symposium on Aspects of Research on Glucocorticoid Receptors, Graupe, K. (ed.) 1983, in press.
J. C. Gasson, T. Ryden, and S. Bourgeois, Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line. Nature 302: 621 (1983).
J. C. Gasson and S. Bourgeois, A new determinant of glucocorticoid sensitivity in lymphoid cell lines. J. Cell Biol. 96: 409 (1983).
W. Doerfler, DNA methylation and gene activity. Ann. Rev. Biochem. 52: 93 (1983).
J. M. Harmon and E. B. Thompson, Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM C7. Mol. Cell. Biol. 1: 512 (1981).
Y. Sakaue and E. B. Thompson, Characterization of two forms of glucocorticoid hormone-receptor complex separated by DEAEcellulose column chromatography. Biochem. Biophys. Res. Commun. 77: 533 (1977).
T. J. Schmidt, J. M. Harmon and E. B. Thompson, ‘Activation-labile’ glucocorticoid-receptor complexes of a steroid-resistant variant of CEM-C7 human lymphoid cells. Nature 286: 507 (1980).
J. M. Harmon, T. J. Schmidt and E. B. Thompson, Molybdatesensitive and molybdate-resistant activation-labile glucocorticoid-receptor mutants of the human lymphoid cell line CEM-C7. J. Steroid Biochem. 21: 227 (1984).
S. S. Simons, Jr. and E. B. Thompson, Dexamethasone-21-mesylate: an affinity label of glucocorticoid receptors from rat hepatoma tissue culture cells. Proc. Natl. Acad. Sci. USA 78: 3541 (1981).
J. M. Harmon, H. J. Eisen, S. T. Brower, S. S. Simons, Jr., C. L. Langley and E. B. Thompson, Identification of human leukemic glucocorticoid receptors using affinity labeling and anti-human glucocorticoid receptor antibodies. Cancer Res. 44: 4540 (1984).
K. L. Leach, M. K. Dahmer, N. D. Hammond, J. J. Sando and W. B. Pratt, Molybdate inhibition of glucocorticoid receptor inactivation and transformation. J. Biol. Chem. 254: 11884 (1979)
J. M. Harmon, E. B. Thompson and K. A. Baione, Analysis of glucocorticoid-resistant human leukemic cells by somatic cell hybridization. J. Steroid Biochem., in press.
J. W. Littlefield, The use of drug-resistant markers to study the hybridization of mouse fibroblasts. Exptl. Cell Res. 41: 190 (1966).
E. B. Thompson, D. K. Granner, T. Gelehrter, J. Erickson and G. L. Hager, Unlinked control of multiple glucocorticoidinduced processes in HTC cells. Mol Cell. Endocrinol. 15: 135 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Thompson, E.B., Harmon, J.M. (1986). Glucocorticoid Receptors and Glucocorticoid Resistance in Human Leukemia in Vivo and in Vitro . In: Chrousos, G.P., Loriaux, D.L., Lipsett, M.B. (eds) Steroid Hormone Resistance. Advances in Experimental Medicine and Biology, vol 196. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5101-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5101-6_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5103-0
Online ISBN: 978-1-4684-5101-6
eBook Packages: Springer Book Archive